Title / AuthorYear
Intestinal short chain fatty acids and their link with diet and human health
D Ríos-Covián, P Ruas-Madiedo, A Margolles, M Gueimonde, ...
Frontiers in microbiology 7, 185
2016
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
MC Dao, A Everard, J Aron-Wisnewsky, N Sokolovska, E Prifti, EO Verger, ...
Gut 65 (3), 426-436
2016
The gut microbiome in health and in disease
AB Shreiner, JY Kao, VB Young
Current opinion in gastroenterology 31 (1), 69
2015
Influence of diet on the gut microbiome and implications for human health
RK Singh, HW Chang, D Yan, KM Lee, D Ucmak, K Wong, M Abrouk, ...
Journal of translational medicine 15 (1), 73
2017
Gut microbiota functions: metabolism of nutrients and other food components
I Rowland, G Gibson, A Heinken, K Scott, J Swann, I Thiele, K Tuohy
European journal of nutrition 57 (1), 1-24
2018
Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial
L Böhn, S Störsrud, T Liljebo, L Collin, P Lindfors, H Törnblom, M Simrén
Gastroenterology 149 (6), 1399-1407. e2
2015
Nonceliac gluten sensitivity
A Fasano, A Sapone, V Zevallos, D Schuppan
Gastroenterology 148 (6), 1195-1204
2015
Akkermansia muciniphila and its role in regulating host functions
M Derrien, C Belzer, WM de Vos
Microbial pathogenesis 106, 171-181
2017
dietary fibre–microbiota interactions
HL Simpson, BJ Campbell
Alimentary pharmacology & therapeutics 42 (2), 158-179
2015
Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis
A Marsh, EM Eslick, GD Eslick
European journal of nutrition 55 (3), 897-906
2016
Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome
BP Chumpitazi, JL Cope, EB Hollister, CM Tsai, AR McMeans, RA Luna, ...
Alimentary pharmacology & therapeutics 42 (4), 418-427
2015
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial
K McIntosh, DE Reed, T Schneider, F Dang, AH Keshteli, G De Palma, ...
Gut 66 (7), 1241-1251
2017
Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena?
M Rajilić-Stojanović, DM Jonkers, A Salonen, K Hanevik, J Raes, ...
The American journal of gastroenterology 110 (2), 278
2015
Systematic review: dietary fibre and FODMAP‐restricted diet in the management of constipation and irritable bowel syndrome
SSC Rao, S Yu, A Fedewa
Alimentary pharmacology & therapeutics 41 (12), 1256-1270
2015
Lactose intolerance in adults: biological mechanism and dietary management
Y Deng, B Misselwitz, N Dai, M Fox
Nutrients 7 (9), 8020-8035
2015
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies
E Distrutti, L Monaldi, P Ricci, S Fiorucci
World journal of gastroenterology 22 (7), 2219
2016
A randomized controlled trial comparing the low FODMAP diet vs. modified NICE guidelines in US adults with IBS-D
SL Eswaran, WD Chey, T Han-Markey, S Ball, K Jackson
American Journal of Gastroenterology 111 (12), 1824-1832
2016
A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores bifidobacterium species: a randomized controlled trial
HM Staudacher, MCE Lomer, FM Farquharson, P Louis, F Fava, ...
Gastroenterology 153 (4), 936-947
2017
Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity
GI Skodje, VK Sarna, IH Minelle, KL Rolfsen, JG Muir, PR Gibson, ...
Gastroenterology 154 (3), 529-539. e2
2018
Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction?
R De Giorgio, U Volta, PR Gibson
Gut 65 (1), 169-178
2016
1 - 20
Dates and citation counts are estimated and are determined automatically by a computer program.